4D is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx, that rationally identifies novel bacteria that have a precise and evolved therapeutic effect. All of 4D's live biotherapeutic products are orally delivered single strains of bacteria that are naturally found in the healthy human gut. 4D currently has a pipeline of 15 therapeutic programmes covering autoimmune diseases, CNS disorders and cancer; with two programmes in patient trials, and the expectation to initiate another three programmes over the coming twelve months.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
52 week high is the highest price of a stock in the past 52 weeks, or one year. 4d Pharma Plc 52 week high is $0.212 as of November 18, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. 4d Pharma Plc 52 week low is $0.212 as of November 18, 2026.
4d Pharma Plc stock price today is $0.212.
4d Pharma Plc stock price yesterday was $0.212.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. 4d Pharma Plc 50-day moving average is $0.212.